药品详细
Succinylcholine(琥珀酰胆碱)
化学结构式图
中文名
琥珀酰胆碱
英文名
Succinylcholine
分子式
C14H30N2O4
化学名
trimethyl[2-({4-oxo-4-[2-(trimethylazaniumyl)ethoxy]butanoyl}oxy)ethyl]azanium
分子量
Average: 290.399
Monoisotopic: 290.220557458
Monoisotopic: 290.220557458
CAS号
306-40-1
ATC分类
M03A 未知
药物类型
small molecule
阶段
approved
商品名
同义名
基本介绍
A quaternary skeletal muscle relaxant usually used in the form of its bromide, chloride, or iodide. It is a depolarizing relaxant, acting in about 30 seconds and with a duration of effect averaging three to five minutes. Succinylcholine is used in surgical, anesthetic, and other procedures in which a brief period of muscle relaxation is called for. [PubChem]
生产厂家
- Apothecon inc div bristol myers squibb
- Hospira inc
- International medication systems ltd
- Organon usa inc
- Sandoz canada inc
封装厂家
参考
Synthesis Reference | Not Available |
General Reference |
|
剂型
规格
化合物类型
Type | small molecule |
Classes |
|
Substructures |
|
适应症
药理
Indication | Used in surgical procedures where a rapid onset and brief duration of muscle relaxation is needed (includes intubation, endoscopies, and ECT) |
Pharmacodynamics | Succinylcholine is indicated as an adjunct to general anesthesia, to facilitate tracheal intubation, and to provide skeletal muscle relaxation during surgery or mechanical ventilation. Succinylcholine is a depolarizing skeletal muscle relaxant. As does acetylcholine, it combines with the cholinergic receptors of the motor end plate to produce depolarization. This depolarization may be observed as fasciculations. Subsequent neuromuscular transmission is inhibited so long as adequate concentration of succinylcholine remains at the receptor site. Succinylcholine has no direct action on the uterus or other smooth muscle structures. |
Mechanism of action | The mechanism of action of Succinylcholine involves what appears to be a "persistent" depolarization of the neuromuscular junction. This depolarization is caused by Succinylcholine mimicking the effect of acetylcholine but without being rapidly hydrolysed by acetylcholinesterase. This depolarization leads to desensitization. |
Absorption | Not Available |
Volume of distribution | Not Available |
Protein binding | Not Available |
Metabolism |
By pseudocholinesterase, to succinylmonocholine and choline.
|
Route of elimination | About 10% of the drug is excreted unchanged in the urine. |
Half life | Not Available |
Clearance | Not Available |
Toxicity | Not Available |
Affected organisms |
|
Pathways | Not Available |
理化性质
Properties | ||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
State | solid | |||||||||||||||||||||||||||||||||||||||
Experimental Properties | Not Available | |||||||||||||||||||||||||||||||||||||||
Predicted Properties |
|
药物相互作用
Drug | Interaction |
---|---|
Amikacin | The agent increases the effect of muscle relaxant |
Clindamycin | The agent increases the effect of muscle relaxant |
Cyclophosphamide | Cyclophosphamide may increase the effect of succinylcholine. |
Dihydrocodeine | May enhance the bradycardic effect of opioid analgesics. It is recommended to monitor therapy. |
Echothiophate | Echothiophate iodide may increase the effect of succinylcholine. |
Gentamicin | The agent increases the effect of muscle relaxant |
Lincomycin | The agent increases the effect of muscle relaxant |
Netilmicin | The agent increases the effect of muscle relaxant |
Piperacillin | The agent increases the effect of the muscle relaxant |
Quinidine | The quinine derivative increases the effect of the muscle relaxant |
Quinine | The quinine derivative increases the effect of the muscle relaxant |
Tacrine | Tacrine may increase the effects of Succinylcholine. Monitor Succinylcholine therapy for increased effects. |
Tobramycin | The agent increases the effect of the muscle relaxant |
食物相互作用
Not Available